Dasatinib Withdrawn Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01410708TORI 104 Pre-Surgical Dasatinib